Differential responses of brain, liver, and muscle glycogen to opiates and surgical stress.
We examined the effects of intracerebroventricular (ICV) cannula implantation followed by the administration of morphine sulfate (MOR) and its metabolite, morphine-6-glucuronide (M6G), on the glycogen content of the brain, liver, and muscle. ICV cannulation resulted in nearly a 30% reduction in brain glycogen, and ICV MOR resulted in a 36% reduction in liver glycogen content compared to time-matched controls, but it had no additional effect on either the brain or muscle glycogen content. ICV M6G showed a more significant reduction, to 50% of liver glycogen, but it had no effect on either brain or muscle glycogen. Neither IV MOR nor M6G produced any significant alteration in tissue glycogen content. These results indicate that the stress response associated with neurosurgery, especially the placement of the ICV cannula, is associated with a decrement in brain glycogen. The activation of opioid receptors in the brain results in enhanced hepatic glycogenolysis but has no additional effect on the brain glycogen content.
Hashiguchi
Y
Y
Department of Surgery, State University of New York at Stony Brook, 11794-8194, USA.
Molina
P E
PE
Boxer
R
R
Naukam
R
R
Abumrad
N N
NN
D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001923:Brain Chemistry; D002404:Catheterization / Q000009:adverse effects*; D002561:Cerebrovascular Disorders / Q000601:surgery*; D006003:Glycogen / Q000032:analysis*; D008099:Liver / Q000737:chemistry; D008297:Male; D009020:Morphine / Q000008:administration & dosage / Q000494:pharmacology*; D009022:Morphine Derivatives / Q000008:administration & dosage / Q000494:pharmacology*; D018482:Muscle, Skeletal / Q000737:chemistry; D051381:Rats; D017207:Rats, Sprague-Dawley
D000701:Analgesics, Opioid; D009022:Morphine Derivatives; C035349:morphine-6-glucuronide; D009020:Morphine; D006003:Glycogen